Advertisement
Screener

NEUROPACE, INC. (NPCE) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

3.4 / 5 stars · 13/19 Roast Me

NEUROPACE, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent

NEUROPACE, INC. (NPCE) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$836.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-05.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2024-03-05

  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-09-30 was $117.00K, a 431.82% increase year-over-year.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-06-30 was -$469.00K.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-03-31 was -$710.00K.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-09-30 was $22.00K, a 450.00% increase year-over-year.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$836.00K.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$305.00K, a 1053.13% decline from fiscal 2020.
  • NEUROPACE, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was $32.00K.
Period endOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month
2022-12-31-$836.00K
10-K · filed 2024-03-05
2022-09-30$117.00K
10-Q · filed 2022-11-08
-$352.00K
derived: sum of 2 quarters · filed 2022-11-08
-$1.06M
derived: sum of 3 quarters · filed 2022-11-08
2022-06-30-$469.00K
10-Q · filed 2022-11-08
-$1.18M
derived: sum of 2 quarters · filed 2022-11-08
2022-03-31-$710.00K
10-Q · filed 2022-11-08
2021-12-31-$305.00K
10-K · filed 2023-03-02
2021-09-30$22.00K
10-Q · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
2021-06-30-$22.00K
10-Q · filed 2022-11-08
2020-12-31$32.00K
10-K · filed 2022-03-10
2020-09-30$4.00K
10-Q · filed 2021-11-10
$41.00K
derived: sum of 2 quarters · filed 2021-11-10
$0.00
derived: sum of 3 quarters · filed 2021-11-10
2020-06-30$37.00K
10-Q · filed 2021-11-10
-$4.00K
derived: sum of 2 quarters · filed 2021-11-10
2020-03-31-$41.00K
10-Q · filed 2021-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39